Leukotrap - Cp2d Solution
Product Images NDC 53157-123
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Leukotrap - Cp2d Solution (NDC 53157-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Haemonetics Manufacturing Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figb (Figb)
This information provides details about a unit of CP2D Red Blood Cells, which contains approximately 500 ml of red blood cells along with 70 ml of CP2D solution. It is to be stored at 1-6 °C. The circular of information includes indications, contraindications, cautions, and infusion methods. The product is from a volunteer donor and could potentially transmit infectious agents, so it is for prescription use only and should be properly identified before use. The provided expiry information mentions the anticoagulant citrate phosphate double dextrose solution used in the collection process. The CP2D solution contains specific amounts of dextrose, sodium citrate, citric acid, and monobasic sodium phosphate. The label indicates the product is for manufacturing by Haemonetics Corporation in Braintree, MA, USA.*
Figc (Figc)
This text provides guidelines for storing platelets at controlled temperatures for up to 5 days and mentions the reduction of leukocytes. It also includes instructions for placing the product label after filling the bag, a caution about potential transmission of infectious agents, and the necessity of proper recipient identification. The information references the manufacturer, Haemonetics Corporation, and their contact details in Braintree, USA. Note: The text contains various typographical errors and may not be complete.*
Figd (Figd)
This is a label for a blood product containing red blood cells suspended in AS-3 solution, with adenine-saline added and leukocytes reduced. It includes information about the sodium content, volume, storage conditions, and potential risk of transmitting infectious agents. The label also provides details on the preservative solution's composition and expiration date, along with instructions for proper identification of the recipient. The product is intended for infusion, and the circular of information should be consulted for further details such as indications, contraindications, and cautions.*
Fige (Fige)
This text provides information about the HAEMONETICS® LEUKOTRAP® RC PL SYSTEM, which is a triple blood bag unit designed for the collection of 500ml of blood and the preparation of red blood cells, plasma, and platelets with pre-storage leukocyte reduction. It describes the contents of each unit, including CP2D and AS-3 solutions, and their composition. The text also mentions the sterile and nonpyrogenic nature of the system, sterilization method, storage instructions, and patent information. It provides manufacturing details for Haemonetics Corporation and Haemonetics Manufacturing Inc. Included are contact information, website, and a barcode for identification purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.